Atragen

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.

2003

2003

Pharmacokinetics of intravenously administered liposomal all-trans-retinoic acid (ATRA) and orally administered ATRA in healthy volunteers.

Bulent Ozpolat, Gabriel López-Berestein, Peter Adamson, C. J. Fu, A. Houston Williams
Journal of pharmacy & pharmaceutical sciences : a…
2003

PURPOSE To determine single-and multiple-dose pharmacokinetics of liposomal-all- trans -retinoic acid (Atragen) following… (More)

Is this relevant?

1999

1999

Assessment of all-trans retinoic acid (ATRA) efficacy as a single agent in primary lymphoid neoplasia.

Nedunchezhian Swaminathan, Gabriel López-Berestein, Stuart Rudikoff
Medical oncology
1999

All-trans retinoic acid (ATRA) is currently widely used in the therapy of acute promyelocytic leukemia and is being tested in… (More)

Is this relevant?

1998

1998

Differences in the lipoprotein distribution of free and liposome-associated all-trans-retinoic acid in human, dog, and rat plasma are due to variations in lipoprotein lipid and protein content.

Kishor M. Wasan, Manisha Ramaswamy, +5 authors P. A. Cossum
Antimicrobial agents and chemotherapy
1998

The objective of the proposed study was to determine the distribution in plasma lipoprotein of free all-trans retinoic acid (ATRA… (More)

Is this relevant?